Product Details

Actemra 80 mg**

Tocilizumab
80 mg/4 mL
Concentrate for solution for infusion

ROA

Intravenous

Applicant Name

Roche Products Limited

NRN

A6-100068

Status

Active


Composition

Each single-dose vial contains: Tocilizumab 80 mg in 4 mL concentrate (20 mg/mL). Tocilizumab is a humanised IgG1 monoclonal antibody against the human interleukin-6 (IL-6) receptor produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology Excipients with known effects: Each 80 mg vial contains 0.10 mmol (2.21 mg) Sodium  

ATC Code

L04AC07  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

4 mL x 1’s; 4 mL x 4’s (in vials)  

Product Description

Concentrate for solution for IV infusion in single-dose 4-mL vial. A preservative-free, sterile clear, colourless to pale yellow solution

Manufacturer Name

Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant

Manufacturer Country

JAPAN  

Approval Date

2022-12-18  

Expiry Date

2027-12-17